Viewing Study NCT03257358


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-06 @ 5:40 AM
Study NCT ID: NCT03257358
Status: COMPLETED
Last Update Posted: 2021-10-07
First Post: 2017-08-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09-19
Start Date Type: ACTUAL
Primary Completion Date: 2019-03-05
Primary Completion Date Type: ACTUAL
Completion Date: 2019-06-28
Completion Date Type: ACTUAL
First Submit Date: 2017-08-18
First Submit QC Date: None
Study First Post Date: 2017-08-22
Study First Post Date Type: ACTUAL
Results First Submit Date: 2020-06-26
Results First Submit QC Date: None
Results First Post Date: 2020-07-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2019-06-13
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2021-10-06
Last Update Post Date: 2021-10-07
Last Update Post Date Type: ACTUAL